In human diseases, Lyn is involved in treatment resistance and progression of chronic myeloid leukemia [9], its decrease affects BCR signalling in systemic lupus erythematosus [10] and also chronic and acute leukemia subtypes showed aberrations of Lyn expression [11]. This evidence concerns the gene LYN and chronic myelogenous leukemia, BCR-ABL1 positive.